FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
CMS leader mum on staffing mandate, delivers ‘back to basics’ message
By
James M. Berklan
Nov 08, 2023
A CMS leader steered clear of staffing mandate talk but highlighted a nursing home workforce campaign, renewed survey priorities, discharge processes and much more Tuesday.
CMS leader balks on broader use of antipsychotic drugs
By
Kimberly Marselas
Apr 25, 2023
One of the nation’s top nursing home regulators is opposed to broadening exclusions for the use of antipsychotic medications, he told attendees of a national conference Friday.
Now that’s crazy
By
Jacqueline Vance, RNC, CDONA/LTC
Apr 25, 2023
I assume by now everybody is frantically auditing their resident’s charts for one word (or a derivative of it): schizophrenia! Because you might be audited for the inappropriate use of antipsychotics.
CMS must allow nursing homes to treat neuropsychiatric symptoms of Alzheimer’s
By
Sue Peschin
Chad Worz
Jan 09, 2024
As we start 2024 anew and recover from family-filled holidays, we may have been reminded that celebrations often serve double duty as an informal assessment of health and well-being — including neuropsychiatric...